Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002294661 | SCV002587435 | uncertain significance | Focal segmental glomerulosclerosis | 2017-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003097858 | SCV003524010 | uncertain significance | not provided | 2023-08-17 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 258 of the CFH protein (p.Pro258Leu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects CFH function (PMID: 34189567). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1712406). This missense change has been observed in individual(s) with CFH-related conditions (PMID: 17089378, 35925583). This variant is present in population databases (rs768526062, gnomAD 0.0009%). |
Genome- |
RCV003454086 | SCV004180752 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454089 | SCV004180753 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454088 | SCV004180754 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454087 | SCV004180755 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005002820 | SCV005629239 | uncertain significance | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2024-06-19 | criteria provided, single submitter | clinical testing |